Magnetic resonance imaging contrast-enhanced relaxometry of breast tumors: an MRI multicenter investigation concerning 100 patients.
暂无分享,去创建一个
Jean-Marc Constans | Pierre-Antoine Eliat | J. D. de Certaines | Francis Joffre | P. Eliat | J. Constans | F. Joffre | D. Vincensini | Dominique Vincensini | Véronique Dedieu | Jacques de Certaines | Joëlle Lacroix | Catherine Bertino | Véronique Bouté | Brigitte de Korvin | Catherine Vincent | Corinne Bailly | V. Dedieu | J. Lacroix | C. Vincent | B. de Korvin | V. Bouté | C. Bailly | C. Bertino
[1] G. Newstead,et al. MR imaging of the breast. , 1995, Radiology.
[2] H Lyng,et al. MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume. , 1995, Magnetic resonance imaging.
[3] U. Fischer,et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions , 2001, European Radiology.
[4] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] W. Kaiser,et al. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.
[6] T W Redpath,et al. Measurement of spin-lattice relaxation times with FLASH for dynamic MRI of the breast. , 1996, The British journal of radiology.
[7] J. Renou,et al. Measurements of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles. , 2003, Magnetic resonance imaging.
[8] F. Kelcz,et al. Critical role of spatial resolution in dynamic contrast‐enhanced breast MRI , 2001, Journal of magnetic resonance imaging : JMRI.
[9] P F Sharp,et al. Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Scott Fields,et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.
[11] M. Leach,et al. Breast imaging technology: Imaging biochemistry - applications to breast cancer , 2000, Breast Cancer Research.
[12] Edison T Liu,et al. Classification of cancers by expression profiling. , 2003, Current opinion in genetics & development.
[13] J. D. de Certaines,et al. Performance assessment and quality control in MRI by Eurospin test objects and protocols. , 1993, Magnetic resonance imaging.
[14] G J Parker,et al. Accurate multislice gradient echo T1 measurement in the presence of non‐ideal RF pulse shape and RF field nonuniformity , 2001, Magnetic resonance in medicine.
[15] A Heinig,et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.
[16] G Brix,et al. Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[17] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[18] S. Heywang-Köbrunner,et al. Contrast-Enhanced MRI of the Breast , 1991 .
[19] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[20] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[21] J L Evelhoch,et al. Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.
[22] A. Haase,et al. Snapshot flash mri. applications to t1, t2, and chemical‐shift imaging , 1990, Magnetic resonance in medicine.
[23] R. Edelman,et al. Magnetic resonance imaging (2) , 1993, The New England journal of medicine.
[24] B K Rutt,et al. Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.
[25] S. Heywang,et al. MR imaging of the breast with Gd-DTPA: use and limitations. , 1989, Radiology.
[26] J. Renou,et al. In vivo tissue extracellular volume fraction measurement by dynamic spin-lattice MRI relaxometry: application to the characterization of muscle fiber types. , 1999, Investigative radiology.
[27] A. Padhani. Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.
[28] G J Parker,et al. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. , 1999, Topics in magnetic resonance imaging : TMRI.
[29] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[30] Heywang-Köbrunner Sh,et al. Contrast-enhanced magnetic resonance imaging of the breast. , 1994, Investigative radiology.
[31] G Brix,et al. Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.